DNA Damage and Repair in Glioblastoma: Emerging Therapeutic Perspectives
Aggressive and therapy-resistant glioblastoma is among the most lethal malignant tumors in humans. Complete surgical resection is often unachievable; therefore, combination chemoradiotherapy is used to target tumor cells residual beyond the resection margin. This approach induces DNA damage in tumor...
Saved in:
| Main Authors: | I. F. Gareev, O. A. Beylerli, S. A. Roumiantsev |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bashkir State Medical University
2025-07-01
|
| Series: | Креативная хирургия и онкология |
| Subjects: | |
| Online Access: | https://www.surgonco.ru/jour/article/view/1085 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phase separation in DNA repair: orchestrating the cellular response to genomic stability
by: Juxin Deng, et al.
Published: (2025-05-01) -
Role of TRAP1 Protein in the Development and Progression of Glioblastoma
by: I. F. Gareev, et al.
Published: (2024-12-01) -
Tumour-intrinsic PDL1 signals regulate the Chk2 DNA damage response in cancer cells and mediate resistance to Chk1 inhibitors
by: Clare E. Murray, et al.
Published: (2024-10-01) -
Clinical outcomes of DNA-damaging agents and DNA damage response inhibitors combinations in cancer: a data-driven review
by: Rick Fontenot, et al.
Published: (2025-06-01) -
Lamin A/C facilitates DNA damage response by modulating ATM signaling and homologous recombination pathways
by: Seong-jung Kim, et al.
Published: (2024-12-01)